nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenosine A2A receptor antagonists in Parkinson's disease: still in the running
|
Antonini, Angelo |
|
2014 |
13 |
8 |
p. 748-749 2 p. |
artikel |
2 |
Capitalising on modifiable risk factors for Alzheimer's disease
|
Biessels, Geert Jan |
|
2014 |
13 |
8 |
p. 752-753 2 p. |
artikel |
3 |
Corrections
|
|
|
2014 |
13 |
8 |
p. 757- 1 p. |
artikel |
4 |
Corrections
|
|
|
2014 |
13 |
8 |
p. 757- 1 p. |
artikel |
5 |
David Gutmann: making science work for patients
|
Thorn, Sheila M |
|
2014 |
13 |
8 |
p. 762- 1 p. |
artikel |
6 |
Development of new treatments for Batten disease
|
Mole, Sara E |
|
2014 |
13 |
8 |
p. 749-751 3 p. |
artikel |
7 |
Does neurology need a faster FDA?
|
Burton, Adrian |
|
2014 |
13 |
8 |
p. 760-761 2 p. |
artikel |
8 |
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
|
Brickshawana, Adipong |
|
2014 |
13 |
8 |
p. 795-806 12 p. |
artikel |
9 |
KIR4.1: another misleading expectation in multiple sclerosis?
|
Filippi, Massimo |
|
2014 |
13 |
8 |
p. 753-755 3 p. |
artikel |
10 |
Learning about the brain with comics
|
Cantor, Abi |
|
2014 |
13 |
8 |
p. 764- 1 p. |
artikel |
11 |
Measures and outcomes
|
Goodrick, Steven |
|
2014 |
13 |
8 |
p. 763- 1 p. |
artikel |
12 |
Neurofibromatosis type 1: a multidisciplinary approach to care
|
Hirbe, Angela C |
|
2014 |
13 |
8 |
p. 834-843 10 p. |
artikel |
13 |
Neuro Film Festival: How do we make someone understand us?
|
Morgan, Jules |
|
2014 |
13 |
8 |
p. 765- 1 p. |
artikel |
14 |
News in brief
|
|
|
2014 |
13 |
8 |
p. 766- 1 p. |
artikel |
15 |
Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study
|
Levin, Sondra W |
|
2014 |
13 |
8 |
p. 777-787 11 p. |
artikel |
16 |
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging
|
Ciccarelli, Olga |
|
2014 |
13 |
8 |
p. 807-822 16 p. |
artikel |
17 |
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
|
Norton, Sam |
|
2014 |
13 |
8 |
p. 788-794 7 p. |
artikel |
18 |
Stroke and cerebrovascular diseases in patients with chronic kidney disease
|
Toyoda, Kazunori |
|
2014 |
13 |
8 |
p. 823-833 11 p. |
artikel |
19 |
Tackling the sports-related concussion crisis
|
The Lancet Neurology, |
|
2014 |
13 |
8 |
p. 747- 1 p. |
artikel |
20 |
The Glasgow Coma Scale at 40 years: standing the test of time
|
Teasdale, Graham |
|
2014 |
13 |
8 |
p. 844-854 11 p. |
artikel |
21 |
The Glasgow Coma Scale: time for critical reappraisal?
|
Laureys, Steven |
|
2014 |
13 |
8 |
p. 755-757 3 p. |
artikel |
22 |
Todd Hardy
|
|
|
2014 |
13 |
8 |
p. 763- 1 p. |
artikel |
23 |
Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
|
Hauser, Robert A |
|
2014 |
13 |
8 |
p. 767-776 10 p. |
artikel |
24 |
Urate and neuroprotection trials
|
Schwarzschild, Michael A |
|
2014 |
13 |
8 |
p. 758- 1 p. |
artikel |
25 |
Urate and neuroprotection trials – Authors' reply
|
Chamorro, Ángel |
|
2014 |
13 |
8 |
p. 758-759 2 p. |
artikel |